Following the first public consultation on Sept. 28, 2020, and the second public consultation on Sept. 29, 2021, China National Medical Products Administration (NMPA) released the finalized Measures for the Management of Cosmetic Adverse Reaction Monitoring (the Measures) on Feb. 21, 2022, which will take effect on Oct. 1, 2022. 1
The Measures is China’s first regulation specifically for the management of cosmetic adverse reaction monitoring. It consists of 7 Chapters and 47 Articles, making systematic requirements for cosmetic adverse reaction monitoring from the aspects of responsibilities and obligations, adverse reaction reporting, analysis and evaluation, as well as adverse reaction investigation, supervision and management, etc.
Highlights of the Measures
1. Establish the national cosmetic adverse reaction monitoring management system, and clarify the responsibilities and obligations of each subject in adverse reaction monitoring
The Measures clarifies the responsibilities and obligations of the subjects related to cosmetic production, testing, registration/notification, sales, and supervision in the monitoring of cosmetic adverse reactions, including 1) NMPA as well as provincial and city and county level Medical Products Administration (MPA)s, 2) national, provincial, and city and county level monitoring institutions, 3) registrants, notifiers, domestic responsible persons, entrusted production enterprises, cosmetic operators, e-commerce platforms, medical institutions, etc.
Special attention should be paid to the obligations of the following subjects:
Subjects | Duties |
Cosmetic registrants and notifiers 2 |
|
Overseas cosmetic registrants and notifiers | Establish an assistance mechanism for active collection, reporting, analysis and evaluation, and investigation and handling of adverse reactions with their domestic responsible persons. |
Cosmetic e-commerce platform operators |
|
Entrusted production enterprises, cosmetic operators |
|
2. Standardize the requirements for each link of cosmetic adverse reaction monitoring
The Measures stipulates that "cosmetics adverse reaction monitoring" refers to the whole process of collecting, reporting, analyzing, evaluating, investigating, and handling of cosmetic adverse reactions. Detailed requirements for each link of cosmetic adverse reaction monitoring are also specified, as listed below:
All Links of Monitoring | Noteworthy Requirements |
Adverse Reaction Collection | Cosmetics registrants and notifiers shall publish current contact information such as telephone number and e-mail to the public through product labels, official websites, etc. They shall actively collect adverse reaction information and report them in a timely manner. |
Adverse Reaction Reporting | 1. Reporting principles The principle of reporting when they are suspicious, that is, any human damage suspected to be caused by the use of cosmetics can be reported as cosmetic adverse reaction.
2. Reporting approaches
|
Adverse Reaction Analysis and Evaluation | Cosmetic registrants and notifiers shall analyze and evaluate the collected or learned adverse reactions, and if necessary, conduct self-inspection on product ingredients, formula, production process, production quality management, storage and transportation and other aspects that may cause adverse reactions.
Cosmetic adverse reactions that are serious and that may cause a greater social impact should be analyzed and evaluated within 20 days and 10 days respectively after being informed. A corresponding self-inspection report should be compiled and submitted to the relevant monitoring institutions and medical products administration departments. |
Adverse Reaction Investigation and Handling |
|
Adverse Reaction Monitoring Records | Cosmetic registrants, notifiers, entrusted production enterprises and medical institutions shall establish and keep cosmetic adverse reaction monitoring records. The records shall be kept for not less than 3 years from the reporting date. Domestic responsible person shall assist in the establishing and keeping the records. The adverse reaction monitoring records shall include at least the information of the reporter; the information, symptoms or signs of the person experienced the adverse reaction; the severity of the adverse reaction; the occurrence date of the adverse reaction; the discovery date of the adverse reaction; the reporting date of the adverse reaction; and the name of the cosmetics used. |
3. Specify that the adverse reactions caused by cosmetics added with new ingredients will be subject to the investigations by provincial medical products administration departments. Risk control measures will be taken if the products are found to have safety risks. Specific regulations will be formulated separately.
The Finalized Edition V.S. The Second Draft
Compared to the second draft, the finalized Measures made a few minor changes, including the adjustments to the time limit for cosmetic stakeholders to report adverse cosmetic reactions.
Report Items | The time limit set by the second draft | The time limit set by the finalized Measures |
General cosmetic adverse reactions | To be reported within 30 days from the date of discovery | To be reported within 30 days from the date of discovery |
Serious cosmetic adverse reactions | To be reported within 7 days from the date of discovery | To be reported within 15 days from the date of discovery |
Cosmetic adverse reactions that may cause significant social impacts | To be reported immediately upon discovery | To be reported within 3 days from the date of discovery |
Imported cosmetics’ adverse reactions found on the overseas market | To be reported immediately upon discovery | To be reported within 7 days from the date of discovery |
Cosmetic adverse reaction information found or complaints received by cosmetics e-commerce platform operators | To be record and transferred to the cosmetics operator on the platform for processing within 3 days | To be record and transferred to the cosmetics operator on the platform for processing within 7 days |
Major information about product quality and safety found or complaints received by cosmetics e-commerce platform operators | To be reported to the local provincial medical products administration departments in writing within 7 days from the date of discovery | To be reported to the local provincial medical products administration departments in writing within 15 days from the date of discovery |
ChemLinked Comments
In the past, cosmetic enterprises invested relatively low in adverse reaction monitoring. However, since the Measures for the Management of Cosmetic Adverse Reaction Monitoring has driven the demand for cosmetic enterprises in the monitoring and management of cosmetic adverse reactions, the cosmetic industry may face a reshuffling environment with a group of enterprises to be eliminated. Therefore, cosmetic enterprises shall seriously put the monitoring work of adverse reactions on the agenda.
For cosmetic registrants and notifiers, the necessity of carrying out adverse reaction monitoring and establishing a monitoring and evaluation system per the Measures will undoubtedly increase the business cost and workload. They need to shoulder more responsibilities in the future.
* If you have any further cosmetic compliance consultation or need translation service of the full Measures, please feel free to contact us at [email protected].
Request a Demo

We provide full-scale global cosmetic market entry services (including cosmetic registering & filing, regulatory consultation, customized training, market research, branding strategy). Please contact us to discuss how we can help you by 






